
    
      Patients with non-infectious and idiopathic uveitis will receive standard treatment with
      methylprednisolone, but will be randomized to receive either Beta-1,3/1,6-D-Glucan from
      mycelium extract of Indonesian Ganoderma lucidum or placebo. Follow up will be performed on
      week-2, week-4, week-6, month-2, and month-3. Outcomes measured are anterior chamber cells,
      visual acuity, and serum TNF-alpha levels.
    
  